NWLI 272.01 National Western Life Insurance $NWLI Hit a 52

New Post Public Reply Private Reply Replies (0) Message Board

Nov 4, 2014 at 12:44 AM

NWLI 272.01 National Western Life Insurance $NWLI Hit a 52 week high of 280.02 Closing the day 11/03/14 at 272.01 +1.01 +0.37% With a day low of 270.00 and a total volume of 10,872.

NWLI Recent Posts: http://investorshangout.com/National-Western-...WLI-54944/

NWLI National Western Life Insurance Recent Headline News

National Western Life Announces 2014 Second Quarter Earnings
PR Newswire - Thu Aug 07, 12:00PM CDT
Ross R. Moody, President of National Western Life Insurance Company (Nasdaq: NWLI), announced today second quarter 2014 consolidated net earnings of $29.2 million, or $8.25 per diluted Class A common share, compared with consolidated net earnings of $27.0 million, or $7.62 per diluted Class A common share, for the second quarter of 2013. For the six months ended June 30, 2014, the Company reported consolidated net earnings of $49.0 million, or $13.86 per diluted Class A common share, compared with $43.6 million, or $12.32 per diluted Class A common shares, a year ago. The Company's book value per share increased to $416.89 as of June 30, 2014 from $406.54 at March 31, 2014.
NWLI: 272.01 (+1.01)

Lincoln National Touches 52-Week High on Favorable Developments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 8:50AM CDT
On Jul 3, 2014, shares of Lincoln National Corporation (LNC) reached a new 52-week high of $53.77.
NWLI: 272.01 (+1.01), MET: 54.30 (+0.06), LNC: 54.57 (-0.19), AEG: 8.06 (-0.11)

National Western Life Insurance Shares Up 12.6% Since SmarTrend's Buy Recommendation (NWLI)
Comtex SmarTrend(R) - Tue Apr 01, 11:15AM CDT
SmarTrend identified an Uptrend for National Western Life Insurance (NASDAQ:NWLI) on February 26th, 2014 at $219.76. In approximately 1 month, National Western Life Insurance has returned 12.63% as of today's recent price of $247.50.
NWLI: 272.01 (+1.01)

National Western Life Insurance Has Returned 14.4% Since SmarTrend Recommendation (NWLI)
Comtex SmarTrend(R) - Tue Mar 25, 9:52AM CDT
SmarTrend identified an Uptrend for National Western Life Insurance (NASDAQ:NWLI) on February 26th, 2014 at $219.76. In approximately 4 weeks, National Western Life Insurance has returned 14.36% as of today's recent price of $251.31.
NWLI: 272.01 (+1.01)

National Western Life Announces 2013 Fourth Quarter and Full Year Earnings
PR Newswire - Fri Mar 07, 1:00PM CST
Ross R. Moody, President of National Western Life Insurance Company (Nasdaq: NWLI), announced today fourth quarter 2013 consolidated net earnings of $27.8 million, or $7.87 per diluted Class A common share, compared with consolidated net earnings of $25.2 million, or $7.14 per diluted Class A common share, for the fourth quarter of 2012. For the year ended December 31, 2013, the Company reported consolidated net earnings of $96.2 million, or $27.19 per diluted Class A common share, compared with $92.6 million, or $26.19 per diluted Class A common share, a year ago. The Company's book value per share increased to $398.36 as of December 31, 2013 from $382.37 at December 31, 2012.
NWLI: 272.01 (+1.01)

OTC Daily Alert Stock Watch - National Western Life Insurance Company (NASDAQ: NWLI)
WorldStockWire - Mon Sep 02, 3:15AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
NWLI: 272.01 (+1.01)

Uptrend Call Working As National Western Life Insurance Stock Rises 21.1% (NWLI)
Comtex SmarTrend(R) - Fri Jul 26, 11:11AM CDT
SmarTrend identified an Uptrend for National Western Life Insurance (NASDAQ:NWLI) on April 29th, 2013 at $181.02. In approximately 3 months, National Western Life Insurance has returned 21.09% as of today's recent price of $219.20.
NWLI: 272.01 (+1.01)

National Western Life Insurance Has Returned 20.9% Since SmarTrend Recommendation (NWLI)
Comtex SmarTrend(R) - Fri Jul 19, 9:39AM CDT
SmarTrend identified an Uptrend for National Western Life Insurance (NASDAQ:NWLI) on April 29th, 2013 at $181.02. In approximately 3 months, National Western Life Insurance has returned 20.93% as of today's recent price of $218.91.
NWLI: 272.01 (+1.01)

17.0% Return Seen to Date on SmarTrend National Western Life Insurance Call (NWLI)
Comtex SmarTrend(R) - Fri Jul 12, 9:05AM CDT
SmarTrend identified an Uptrend for National Western Life Insurance (NASDAQ:NWLI) on April 29th, 2013 at $181.02. In approximately 2 months, National Western Life Insurance has returned 17.03% as of today's recent price of $211.85.
NWLI: 272.01 (+1.01)

National Western Life Insurance Company Selects StoneRiver LifeApply® to Replace Existing Electronic Application Solution
PR Newswire - Tue Jun 18, 7:00AM CDT
StoneRiver, Inc., the trusted insurance technology partner with solutions across multiple business lines, today announced that National Western Life Insurance Company, a provider of high quality insurance products, has selected StoneRiver's LifeApply® electronic application as its sole solution across all distribution channels.
NWLI: 272.01 (+1.01)

A.M. Best Affirms Ratings of National Western Life Insurance Company
Business Wire - Thu May 23, 11:27AM CDT
A.M. Best Co. has affirmed the financial strength rating of A (Excellent) and issuer credit rating of "a" of National Western Life Insurance Company (NWL) (Denver, CO) (NASDAQ: NWLI). The outlook for both ratings is stable.
NWLI: 272.01 (+1.01)

National Western Life Insurance Company [NWLI] to Ring The NASDAQ Stock Market Opening Bell
GlobeNewswire - Fri May 10, 9:00AM CDT
What:
NWLI: 272.01 (+1.01), NDAQ: 43.53 (+0.27)

National Western Life Announces 2013 First Quarter Earnings
PR Newswire - Mon May 06, 10:30AM CDT
Ross R. Moody, President of National Western Life Insurance Company (Nasdaq: NWLI), announced today first quarter 2013 consolidated net earnings of $16.6 million, or $4.70 per diluted Class A common share, compared with consolidated net earnings of $19.7 million, or $5.58 per diluted Class A common share, for the first quarter of 2012. The Company's book value per share increased to $387.08 as of March 31, 2013 from $382.88 at December 31, 2012.
NWLI: 272.01 (+1.01)

Healthy Vending Franchise Continues Opening New Doors Nationwide
PRWeb - Thu May 02, 5:48AM CDT
Fresh Healthy Vending the category leader in healthy vending services secured 86 contracts for new locations across the country looking to take the initiative and sign up for a healthy vending program. The company secures these contracts on behalf its network of healthy vending franchisees across the country.
NWLI: 272.01 (+1.01)

WEALTHMAKERS.COM Issues Bearish Research Reports on AHC, KAR, KIOR, NWLI, NYX, PCCC
M2 - Wed Mar 20, 10:58AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: A. H. Belo Corp (NYSE:AHC), KAR AUCTION SERVICES INCORPORATION (NYSE:KAR), KiOR Inc (NASDAQ:KIOR), National Western Life Insurance Co (NASDAQ:NWLI), NYSE Euronext (NYSE:NYX), PC Connection Inc (NASDAQ

CCC)
NWLI: 272.01 (+1.01), AHC: 11.50 (-0.01), KAR: 30.43 (+0.07), PCCC: 22.87 (-0.98)

National Western Life Insurance Co. (NWLI) Stock Research Links

NWLI Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...